White label ELPA - ClinicalTrials.eu

Long‑Term Safety Follow‑up of Ornithine Transcarbamylase Deficiency Patients Treated with ECUR‑506D and ECUR‑506A

Recruiting

2 1 1
Investigated Diseases:
- Ornithine transcarbamoylase deficiency
Investigated Drugs:
- Adeno-Associated Virus Serotype Rh79 Containing The Human Otc Gene
Effect of Ferric Carboxymaltose, Ferrous Sulfate, and Sodium Chloride vs Placebo on Physical Performance in Frail Elderly with Iron Deficiency and Cardiovascular Disease

Recruiting

3 1 1
Investigated Diseases:
- Iron deficiency
Investigated Drugs:
Efficacy and safety of human alpha1‑proteinase inhibitor weekly infusions in adults with alpha1 antitrypsin deficiency–related emphysema

Recruiting

3 1 1 1
Investigated Drugs:
- Human Alpha1-Proteinase Inhibitor
Evaluation of Raludotatug Deruxtecan With Carboplatin, Paclitaxel, or Bevacizumab in Relapsed High-grade Serous Ovarian, Peritoneal, or Fallopian Tube Cancer

Recruiting

1 1 1 1
Investigated Drugs:
Efficacy, safety and dose‑response of once‑weekly subcutaneous UBT251 compared with semaglutide in adults with type 2 diabetes

Recruiting

2 1 1
Investigated Drugs:
- Semaglutide
A study testing XmAb942 compared to placebo in adults with moderate-to-severe active ulcerative colitis

Recruiting

2 1
Investigated Drugs:
- XMAB942
+5
Long‑term Safety of Adagrasib with Drug Combination in Adults with Solid Tumors

Recruiting

2 1 1 1
Investigated Diseases:
- Neoplasm
Investigated Drugs:
+5
Study of Camoteskimab and Sodium Chloride Placebo in Adults with Moderate-to-Severe Atopic Dermatitis

Recruiting

2 1 1
Investigated Diseases:
- Dermatitis atopic
Investigated Drugs:
- Sodium Chloride
Safety and Pharmacokinetics of MIB2 (StaphAcute) in Healthy Volunteers and Patients with Staphylococcus aureus Bacteremia

Recruiting

2 1 1
Investigated Diseases:
- Staphylococcal bacteraemia
Investigated Drugs:
- Sodium Chloride
A Randomized Double‑Blind Study of Pharmacokinetic Similarity of AVT32‑DRL_PB and Pembrolizumab in Patients with Resected Stage IIB‑C‑III Melanoma

Recruiting

3 1 1 1
Investigated Drugs:
- Pembrolizumab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies